RxSight
RXST
49 hedge funds and large institutions have $131M invested in RxSight in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 7 closing their positions.
229% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 7
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
21% more capital invested
Capital invested by funds: $108M → $131M (+$22.7M)
9% more funds holding
Funds holding: 45 → 49 (+4)
1.9% more ownership
Funds ownership: 31.92% → 33.83% (+1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.73M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$2.32M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.79M |
| 4 |
BM
Bridger Management
New York
|
+$1.75M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.73M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$1.75M |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$329K |
| 4 |
SW
SVB Wealth
Boston,
Massachusetts
|
-$251K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$217K |
RXST Hedge Fund Activity: Q2 2022 in Review
49 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q2 2022, worth a combined $131M — up 21% from $108M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new RXST positions and 7 closed out — a net gain of 5 holders — while 23 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $2.73M. The largest seller was Millennium Management, cutting an estimated $5.73M.
- 49 institutional investors held RxSight (RXST) as of Q2 2022, up from 45 in Q1 2022.
- Funds reported $131M of RxSight stock for Q2 2022, up 21% quarter-over-quarter.
- 12 funds opened new RxSight positions in Q2 2022 and 7 closed out, a net change of +5 holders.
- The largest RxSight buyer in Q2 2022 was BlackRock, an estimated $2.73M added.
- The largest RxSight seller in Q2 2022 was Millennium Management, an estimated $5.73M sold.
Based on aggregated 13F filings for Q2 2022.